• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Transcatheter aortic-valve replacement noninferior to surgery in intermediate-risk patients: The PARTNER 2 study

byJames RoebkerandShaidah Deghan, MSc. MD
April 28, 2016
in Cardiology, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. For intermediate-risk surgical candidates with aortic stenosis, transcatheter aortic-valve replacement (TAVR) was non-inferior to surgical aortic-valve replacement based on all-cause death and disabling stroke at 2 years, as well as 30-day clinical endpoints.

2. TAVR had better aortic valve area and gradient compared to surgery based on echocardiographic findings, but a higher incidence of paravalvular aortic regurgitation.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Aortic stenosis, characterized by a long period of latency followed by a rapidly progressing symptomatic stage, carries high mortality if left untreated. Since aortic valve replacement is the only definitive therapy, TAVR was developed as a less invasive way to insert a bioprosthetic valve in patients who are considered unsuitable for surgery. In these high-risk patients, TAVR has been established as superior to other therapeutic options; however, TAVR had not been previously compared to surgery.

This multicenter randomized controlled trial (PARTNER 2) compared outcomes of TAVR and surgery for intermediate-risk patients. Based on the results, TAVR appears to be at least as effective as surgery for treating aortic stenosis in intermediate-risk patients at the 2-year follow-up. The study showed no difference in all-cause death or disabling stroke at 2 years. Furthermore, the transfemoral cohort had a significantly lower all-cause death rate and disabling stroke than surgery. Of the 30 day clinical outcomes major vascular complications were more frequent in the TAVR group compared to the surgery group. TAVR showed a significant increase in aortic valve area and decrease in aortic-valve gradients; however, paravalvular regurgitation was significantly higher in the TAVR cohort. A significantly higher number of TAVR patients were noted to have mild regurgitation at 2 years. Longer follow-up may be needed to assess further progression and the durability of TAVR.

Click to read the study, published today in NEJM

RELATED REPORTS

#VisualAbstract: Transcatheter Aortic-Valve Replacement not associated with improved five-year outcomes compared to surgery in low-risk patients

Repeat transcatheter aortic valve replacement after initial attempt is generally safe in patients with balloon-expandable valves

Cerebral embolic protection during transcatheter aortic-valve replacement does not reduce the incidence of stroke

Relevant Reading: Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery

In-Depth [randomized controlled trial]: This PARTNER 2 trial enrolled 2032 patients randomized to either TAVR (n=1011) or surgery (n=1021). Within the TAVR cohort, 236 patients (23.3%) were assigned transthoracic placement and the remaining to transfermoral placement. All patients were assessed with validated criteria from the Society of Thoracic Surgeons as intermediate-risk for surgery. The primary end point was all-cause death or disabling stroke at 2 years. Short-term clinical end points were assessed at 30 days and included major vascular complications, life-threatening bleeding, acute kidney injury, new-onset atrial fibrillation, need for new pacemakers, and endocarditis.

No difference in all-cause death or disabling stroke was found between TAVR and surgery at 2 years (risk ratio = 0.92, p<0.001), meeting the criterion for noninferiority. The transfemoral cohort had a lower all-cause death rate and disabling stroke than surgery (HR in the intention-to-treat analysis, 0.79; 95% [CI], 0.62 to 1.00; p=0.05). Of the 30 day clinical outcomes, only major vascular complications were more frequent in TAVR compared to surgery (TAVR 7.9% vs. surgery 5.0%, p=0.008). Life-threatening bleeding (10.4% vs. 43.4%, p<0.001), acute kidney injury (1.3% vs. 3.1%, p=0.006), and new-onset atrial fibrillation (9.1% vs. 26.4%, p<0.001) were all less frequent in TAVR. Repeat hospitalization at 2 years, need for new pacemakers, and endocarditis were all similar between the two cohorts.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: aortic valve replacementTranscatheter aortic valve replacement
Previous Post

Night shift work associated with risk of coronary heart disease

Next Post

Natural language processing may automate data extraction from radiologic reports

RelatedReports

#VisualAbstract: Transcatheter Aortic-Valve Replacement not associated with improved five-year outcomes compared to surgery in low-risk patients
StudyGraphics

#VisualAbstract: Transcatheter Aortic-Valve Replacement not associated with improved five-year outcomes compared to surgery in low-risk patients

November 29, 2023
Quick Take: Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse
Cardiology

Repeat transcatheter aortic valve replacement after initial attempt is generally safe in patients with balloon-expandable valves

November 15, 2023
Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Cardiology

Cerebral embolic protection during transcatheter aortic-valve replacement does not reduce the incidence of stroke

October 10, 2022
#VisualAbstract: Inequities in aortic stenosis and aortic valve replacement between Black/African American, White, and Hispanic patients
StudyGraphics

#VisualAbstract: Inequities in aortic stenosis and aortic valve replacement between Black/African American, White, and Hispanic patients

July 28, 2021
Next Post
Natural language processing may automate data extraction from radiologic reports

Natural language processing may automate data extraction from radiologic reports

Rapid time to revascularization after ischemic stroke associated with improved functional outcomes

Rapid time to revascularization after ischemic stroke associated with improved functional outcomes

Late gestation antidepressant use linked to postpartum hemorrhage

Advanced maternal age associated with obstetric pelvic floor trauma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss
  • Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
  • 2 Minute Medicine Rewind June 23, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.